Medically supervised weight loss with Tirzepatide (Mounjaro / Zepbound)
Injectable weight loss medications represent a major breakthrough in obesity medicine. At Flawless MD, we offer Tirzepatide (marketed as Mounjaro for diabetes and Zepbound for weight loss) — the first FDA-approved dual GIP/GLP-1 receptor agonist shown to produce exceptional weight loss results in clinical trials.
Unlike diet pills or fad approaches, these medications work with your body's own metabolic hormones — reducing appetite, improving blood sugar regulation, and promoting sustained fat loss. All treatment at Flawless MD is physician-supervised by Un Hui Nam, MD, ensuring safe and personalized care.
Tirzepatide activates GIP and GLP-1 receptors in the brain that control hunger signals. Patients experience significantly reduced appetite and earlier satiety — making it easier to maintain a caloric deficit naturally.
Beyond weight loss, Tirzepatide improves insulin sensitivity, lowers blood sugar, reduces inflammation, and has cardiovascular benefits — making it a comprehensive metabolic treatment, not just a weight loss drug.
Dr. Nam reviews your medical history, current medications, and weight loss goals. Labs may be ordered. A personalized dosing schedule is created.
Tirzepatide is administered as a once-weekly subcutaneous injection (self-administered at home with easy-to-use auto-injector pens). Dosing is gradually increased over 4–20 weeks to minimize side effects and maximize tolerability.
Clinical trials show average weight loss of 15–22% of body weight over 12–16 months. Regular check-ins with Dr. Nam ensure dose optimization, safety monitoring, and progress tracking.
The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation — particularly during dose escalation. These are usually mild and improve as your body adjusts. Slow titration significantly reduces side effect burden. Serious side effects are rare and are reviewed in depth during your consultation.
In the landmark SURMOUNT-1 clinical trial, patients on the maximum dose of Tirzepatide lost an average of 22.5% of body weight over 72 weeks. Individual results vary based on starting weight, adherence, diet, and activity level.
Weight loss medications work best as long-term treatments. Significant weight regain is common when the medication is stopped without concurrent lifestyle changes. Dr. Nam works with you to build sustainable habits alongside medication therapy for lasting results.
Yes. Tirzepatide is an FDA-approved prescription medication. Dr. Nam evaluates each patient individually to determine suitability and writes the appropriate prescription. All treatment is physician-supervised.
Evidence-based weight loss with personalized medical oversight — every step of the way.
BOOK AN APPOINTMENT